How immune-supporting cells shape early-stage bladder cancer
Project 1
This project looks at how certain immune-supporting cells and local immune structures in early-stage bladder cancer affect which tumors may become more dangerous, focusing on people with non-muscle-invasive bladder cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Methodist Hospital Research Institute NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11192229 on NIH RePORTER |
What this research studies
From my viewpoint as a patient, researchers will examine tissue from people with non-muscle-invasive bladder cancer to look for organized immune structures called tertiary lymphoid structures (TLS). They will also use a mouse model that mimics early bladder lesions to reproduce the TLS pattern and study it in a controlled setting. Using single-cell RNA sequencing, the team will search for a specific population of "immunofibroblast" cells that help organize TLS alongside B cells and lymphoid tissue inducer cells. The goal is to link these immune scaffolds to which early tumors progress and to improve risk sorting for patients.
Who could benefit from this research
Good fit: Ideal candidates are people diagnosed with non-muscle-invasive bladder cancer who can provide tumor tissue or consent to have their specimens analyzed.
Not a fit: Patients with already muscle-invasive bladder cancer or those unable or unwilling to provide tissue samples are unlikely to benefit directly from this project.
Why it matters
Potential benefit: If successful, this work could help doctors identify which early bladder tumors are likely to become invasive and point to ways to strengthen local anti-tumor immunity.
How similar studies have performed: Other cancer studies have linked tertiary lymphoid structures to better anti-tumor responses, but applying the immunofibroblast/TLS idea to early bladder cancer is a novel approach.
Where this research is happening
Houston, United States
- Methodist Hospital Research Institute — Houston, United States (Active)
Researchers
- Principal investigator: Chan, Keith Syson — Methodist Hospital Research Institute
- Study coordinator: Chan, Keith Syson
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.